EFFECTS OF AGING ON VACCINE EFFICACY IN NONHUMAN PRIMATE MODELS
EFFECTS OF AGING ON VACCINE EFFICACY IN NONHUMAN PRIMATE MODELS
批准号:
8357689
负责人:
ELLEN KRAIG
金额:
$16.47万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30
关键词:
AddressAgeAgingAntigensBacteriaBiomedical ResearchCallithrixCommunicable DiseasesCompetenceDrug FormulationsElderlyFundingGrantHumanImmuneImmune responseImmunityIndividualLeftMacaca mulattaMalignant NeoplasmsModelingNational Center for Research ResourcesPapioPlaguePopulationPrimatesPrincipal InvestigatorResearchResearch InfrastructureResourcesRodentSourceTestingUnited States National Institutes of HealthVaccinesage effectage relatedcostimmune functionjuvenile animalnonhuman primatenovel vaccinessenescencevaccine efficacyvaccine evaluation
中文摘要
这个子项目是利用资源的许多研究子项目之一。
由NIH/NCRR资助的中心拨款提供。对子项目的主要支持
子项目的首席调查员可能是由其他来源提供的,
包括美国国立卫生研究院的其他来源。为子项目列出的总成本可能
表示该子项目使用的中心基础设施的估计数量,
不是由NCRR赠款提供给次级项目或次级项目工作人员的直接资金。
人类发动有效免疫反应的能力随着年龄的增长而下降,这使得老年人容易感染传染病和癌症。此外,在年轻人身上测试的疫苗对老年人往往无效。因此,随着新疫苗的开发,测试这些配方对老年人和年轻人的有效性将是极其重要的。虽然年轻的非人灵长类动物在测试普通人类群体的疫苗效力方面起到了关键作用,但使用老年非人灵长类动物来评估老年人疫苗保护的模型尚未建立。我们已经开始解决这个问题,在最近的一项研究中,令我们惊讶的是,在生物医学研究中广泛使用的一种非人类灵长类物种狒狒并没有随着年龄的增长而表现出免疫衰老。事实上,当老年狒狒(19-24岁)用LcrV免疫时,它们的反应甚至比年轻动物(2岁)更好。LcrV是一种针对鼠疫细菌的保护性抗原。因此,尽管在人类、啮齿动物和一些非人类灵长类物种中观察到了与年龄相关的免疫功能丧失,但狒狒似乎是不寻常的;它们在衰老时不会失去免疫能力。因此,我们建议评估衰老对三种非人类灵长类动物(狒狒、猕猴和绒猴)对多种不同抗原免疫的影响。
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The ability of humans to mount an effective immune response declines with age, leaving the elderly susceptible to infectious diseases and cancer. Moreover, vaccines tested in younger individuals are often ineffective in older people. Thus, as new vaccines are developed, it will be extremely important to test these formulations for efficacy in the elderly as well as in the young. While young nonhuman primates have been critical in testing vaccine efficacy for the general human population, a model using old nonhuman primates to assess vaccine protection for the elderly has not been established. We have begun to address this issue and in a recent study, found to our surprise that baboons, a nonhuman primate species used extensively in biomedical research, did not show immune senescence with aging. In fact, when old baboons (19-24 years old) were immunized with LcrV, a protective antigen from the plague bacterium, they responded even better than young animals (2¿ years old). Thus, although age-related loss in immune function has been observed in humans, rodents and a few nonhuman primate species, baboons appear to be unusual; they age without losing immune competence. Therefore, we propose to assess the effects of aging on immunity in three nonhuman primate species (baboons, rhesus macaques, and marmosets) to multiple different antigens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maternal nutrient restriction: Effects on offspring immune function
-
批准号:8433316
-
项目类别:
-
资助金额:$21.28万
-
财政年份:2012
-
负责人:ELLEN KRAIG
-
依托单位:
Maternal nutrient restriction: Effects on offspring immune function
-
批准号:8284123
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2012
-
负责人:ELLEN KRAIG
-
依托单位:
EFFECTS OF AGING ON VACCINE EFFICACY IN NONHUMAN PRIMATE MODELS
-
批准号:8172716
-
项目类别:
-
资助金额:$7.14万
-
财政年份:2010
-
负责人:ELLEN KRAIG
-
依托单位:
THE EFFECTS OF AGING IN NONHUMAN PRIMATES
-
批准号:8172690
-
项目类别:
-
资助金额:$0.21万
-
财政年份:2010
-
负责人:ELLEN KRAIG
-
依托单位:
Effects of aging on vaccine efficacy in non human primate models
-
批准号:8055013
-
项目类别:
-
资助金额:$55.03万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
Effects of aging on vaccine efficacy in non human primate models
-
批准号:7907218
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
THE EFFECTS OF AGING IN NONHUMAN PRIMATES
-
批准号:7957946
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
Effects of aging on vaccine efficacy in non human primate models
-
批准号:7653192
-
项目类别:
-
资助金额:$54.52万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
Effects of aging on vaccine efficacy in non human primate models
-
批准号:7781318
-
项目类别:
-
资助金额:$42.42万
-
财政年份:2009
-
负责人:ELLEN KRAIG
-
依托单位:
USE OF RECALL IMMUNITY TO ENHANCE VACCINE EFFICACY IN THE ELDERLY
-
批准号:7349836
-
项目类别:
-
资助金额:$2.77万
-
财政年份:2006
-
负责人:ELLEN KRAIG
-
依托单位:
USE OF RECALL IMMUNITY TO ENHANCE VACCINE EFFICACY IN THE ELDERLY
-
批准号:7165398
-
项目类别:
-
资助金额:$2.23万
-
财政年份:2005
-
负责人:ELLEN KRAIG
-
依托单位:
NOVEL APPROACH TO CHLAMYDIA VACCINE DEVELOPMENT
-
批准号:6824520
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2004
-
负责人:ELLEN KRAIG
-
依托单位:
NOVEL APPROACH TO CHLAMYDIA VACCINE DEVELOPMENT
-
批准号:6886809
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2004
-
负责人:ELLEN KRAIG
-
依托单位:
NOVEL APPROACH TO CHLAMYDIA VACCINE DEVELOPMENT
-
批准号:7228617
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2004
-
负责人:ELLEN KRAIG
-
依托单位:
NOVEL APPROACH TO CHLAMYDIA VACCINE DEVELOPMENT
-
批准号:7058323
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2004
-
负责人:ELLEN KRAIG
-
依托单位:
T CELL RESPONSE TO A PERIODONTAL PATHOGEN
-
批准号:6350608
-
项目类别:
-
资助金额:$21.52万
-
财政年份:1999
-
负责人:ELLEN KRAIG
-
依托单位:
T CELL RESPONSE TO A PERIODONTAL PATHOGEN
-
批准号:6150549
-
项目类别:
-
资助金额:$20.89万
-
财政年份:1999
-
负责人:ELLEN KRAIG
-
依托单位:
T CELL RESPONSE TO A PERIODONTAL PATHOGEN
-
批准号:2766716
-
项目类别:
-
资助金额:$20.49万
-
财政年份:1999
-
负责人:ELLEN KRAIG
-
依托单位:
T CELL RESPONSE TO A PERIODONTAL PATHOGEN
-
批准号:6498068
-
项目类别:
-
资助金额:$21.83万
-
财政年份:1999
-
负责人:ELLEN KRAIG
-
依托单位:
AGING AND AUTOIMMUNE MYASTHENIA GRAVIS
-
批准号:2002461
-
项目类别:
-
资助金额:$7.25万
-
财政年份:1997
-
负责人:ELLEN KRAIG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: